SHELTON, CT / ACCESS Newswire / July 21, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.: NNVC ) (the ...

Cancer patients who receive COVID boosters are far less likely to be hospitalized, but vaccination rates remain alarmingly ...

New bacterial mRNA vaccine technology shows promise in fighting plague, and could help address the global threat of ...

New RNA vaccine shows promise in turning resistant tumors into immunotherapy targets. Study offers hope for more effective, ...

A new study of more than 1.2 million people found no link between aluminum in childhood vaccines and long-term health ...

Following on from their breakthrough human trial that successfully reprogrammed the immune system to overpower glioblastoma, ...

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

Scientists have found that mesenchymal stromal cells, or MSC therapy, in combination with antiviral drugs, helped cats’ ...

The health secretary has made many inaccurate statements about vaccines. But the science is clear that vaccines have ...

In the newly released "Paediatric drug optimization for respiratory syncytial virus (PADO-RSV) meeting report" by Global ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Back in high school chemistry, I remember waiting with my bench partner for crystals to form on our stick in the cup of blue solution. Other groups ...